Dr Matthew Rooney PhD MSci
Senior Assay Development Scientist
Studied vaccine adjuvants models at the University of Surrey. Matt joined Fleet in 2021 having previously worked on a variety of ELISA based assays including the development of high throughput assays for Siemens Healthcare. He has experience in raising polyclonal antibodies for a variety of purposes including point of care testing and has performed roles from proof-of-concept reporting to assays transfer.
Does Dysregulation of Redox State Underpin the Decline of Innate Immunity with Aging? Helen R. Griffiths, Matthew C.O. Rooney, and Yvonne Perrie. Antioxidants & Redox Signaling, Volume: 32 Issue 13: March 24, 2020